Lesser Poland Cracovian Heart Failure Registry
LECRA-HF
1 other identifier
observational
2,500
1 country
1
Brief Summary
The goal of Lesser Poland Cracovian Heart Failure Registry (LECRA-HF) is to expand the knowledge about acute heart failure (AHF) and its long-term prognosis. The main questions are:
- assessment of long-term prognosis of AHF and its determinants
- determination of the optimal AHF treatment methods
- assessment of indications for invasive coronary arteries diagnostics and revascularization and their long-term effects
- analysis of the particular HF subtypes (HFimpEF, HFpEF, HFsnEF, HFrEF, HFmrEF)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 15, 2023
CompletedFirst Submitted
Initial submission to the registry
February 17, 2023
CompletedFirst Posted
Study publicly available on registry
February 28, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedMarch 6, 2024
March 1, 2024
1.9 years
February 17, 2023
March 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
All-cause mortality
Mortality due to all causes
2 years
Secondary Outcomes (2)
Cardiovascular mortality
2 years
HF rehospitalizations
2 years
Other Outcomes (1)
LVEF increase >10% in the follow-up echocardiography
2 years
Study Arms (1)
LECRA-HF patients
The study population consists of hospitalized patients with acute heart failure who are over 18 years of age, both women and men. Patients will be initially categorized into one of three groups based on the current European Society of Cardiology (ESC) heart failure guidelines based on left ventricular ejection fraction (LVEF) values: patients with reduced (LVEF ≤40%), mildly reduced (LVEF 41-49%) and preserved (LVEF ≥50%) ejection fraction.
Eligibility Criteria
The study population consists of hospitalized patients with acute heart failure who are over 18 years of age, both women and men. Patients will be initially categorized into one of three groups based on the current European Society of Cardiology (ESC) heart failure guidelines based on left ventricular ejection fraction (LVEF) values: patients with reduced (LVEF ≤40%), mildly reduced (LVEF 41-49%) and preserved (LVEF ≥50%) ejection fraction.
You may qualify if:
- hospitalization due to acute heart failure
- \> 18 years of age
You may not qualify if:
- inability to give informed consent to participate in the registry
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Coronary Disease and Heart Failure, John Paul II Hospital in Krakow, Jagiellonian University Medical College
Krakow, 31-202, Poland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jadwiga Nessler, Prof.
Department of Coronary Disease and Heart Failure, John Paul II Hospital in Krakow
- PRINCIPAL INVESTIGATOR
Konrad Stępień, MD
Department of Coronary Disease and Heart Failure, John Paul II Hospital in Krakow
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
February 17, 2023
First Posted
February 28, 2023
Study Start
February 15, 2023
Primary Completion
December 31, 2024
Study Completion (Estimated)
December 31, 2026
Last Updated
March 6, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share